Page 12 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 12
Contributors ix
Paolo F. Caimi, MD John P. Chute, MD
Seidman Cancer Center, Division of Hematology and Oncology, Professor of Medicine and Radiation Oncology, Division of
Case Comprehensive Cancer Center, University Hospitals, Case Hematology/Oncology, Broad Stem Cell Research Center,
Medical Center, Cleveland, Ohio University of California, Los Angeles, Los Angeles, California
Pharmacology and Molecular Mechanisms of Antineoplastic Agents for Hematopoietic Stem Cell Biology
Hematologic Malignancies
David B. Clark, PhD
Michael A. Caligiuri, MD President, Platte Canyon Consulting, Inc., Shawnee, Colorado;
JL Marakas Nationwide Insurance Enterprise Foundation Chair Chairman, The Coalition for Hemophilia B, New York, New York
of Cancer Research, Director, Comprehensive Cancer Center, Preparation of Plasma-Derived and Recombinant Human Plasma
Department of Internal Medicine, Division of Hematology, The Proteins
Ohio State University Comprehensive Cancer Center, Columbus,
Ohio Thomas D. Coates, MD
Natural Killer Cell Immunity Professor of Pediatrics and Pathology, University of Southern
California Keck School of Medicine; Division Head for
Michelle Canavan, MB, PhD Hematology, Children’s Center for Cancer and Blood Diseases,
Specialist Registrar in Geriatric Medicine, University Hospital Children’s Hospital Los Angeles, Los Angeles, California
Limerick, Limerick, Ireland Disorders of Phagocyte Function
Stroke
Christopher R. Cogle, MD
Alan B. Cantor, MD, PhD Professor of Medicine, Hematology-Oncology, University of
Associate Professor of Pediatrics, Division of Pediatric Hematology/ Florida, Gainesville, Florida
Oncology, Boston Children’s Hospital and Dana-Farber Cancer Regulation of Gene Expression, Transcription, Splicing and RNA
Institute, Harvard Medical School, Boston, Massachusetts Metabolism
Thrombocytopoiesis
Nathan T. Connell, MD, MPH
Manuel Carcao, MD, MSc Instructor in Medicine, Harvard Medical School, Hematology
Hematologist, Division of Haematology/Oncology; Department Division, Brigham and Women’s Hospital, Boston, Massachusetts
of Paediatrics, Senior Associate Scientist, Child Health Evaluative The Spleen and Its Disorders
Sciences, Research Institute; The Hospital for Sick Children,
Associate Professor of Pediatrics, University of Toronto, Toronto, Elizabeth Cooke, RN, MN, AOCN, PMHNP-BC
Ontario, Canada Nurse Practitioner, City of Hope National Medical Center, Duarte,
Hemophilia A and B California
Psychosocial Aspects of Hematologic Disorders
Michael C. Carroll, PhD
Professor of Pediatrics, Harvard Medical School; Senior Investigator, Sarah Cooley, MD
Program in Cellular and Molecular Medicine, Boston Children’s Associate Professor of Medicine, Department of Medicine, Division
Hospital, Boston, Massachusetts of Hematology, Oncology, and Transplantation, University of
Complement and Immunoglobulin Biology Leading to Clinical Minnesota; Associate Director, Cancer Experimental Therapeutics
Translation Initiative, Masonic Cancer Center, Minneapolis, Minnesota
Natural Killer Cell-Based Therapies
Shannon A. Carty, MD
Assistant Professor, Division of Hematology/Oncology, Department Paolo Corradini, MD
of Medicine, University of Michigan, Ann Arbor, Michigan Professor of Hematology; Chairman, Department of Oncology and
T-Cell Immunity Hemato-oncology, University of Milano, Milan, Italy
T-Cell Lymphomas
Jorge J. Castillo, MD
Physician, Hematologic Malignancies, Dana-Farber Cancer Mark A. Creager, MD
Institute; Assistant Professor, Harvard Medical School, Boston, Director, Heart and Vascular Center, Dartmouth-Hitchcock
Massachusetts Medical Center, Anna Gundlach Huber Professor of Medicine,
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Geisel School of Medicine at Dartmouth, Lebanon, New
Hampshire
Anthony K.C. Chan, MBBS, FRCPC, FRCPath Peripheral Artery Disease
Professor of Pediatrics, McMaster University, Hamilton, Ontario,
Canada Richard J. Creger, PharmD
Disorders of Coagulation in the Neonate Clinical Associate Professor of Medicine, Case Western Reserve
University School of Medicine, Cleveland, Ohio
John Chapin, MD Pharmacology and Molecular Mechanisms of Antineoplastic Agents for
Assistant Professor of Medicine, Weill Cornell Medicine; Assistant Hematologic Malignancies
Attending Physician, Hematologic Oncology, NewYork-Presbyterian
Hospital, New York, New York Caroline Cromwell, MD
Thalassemia Syndromes Assistant Professor of Hematology/Oncology, Mount Sinai
Hospital, New York, New York
April Chiu, MD Hematologic Changes in Pregnancy
Associate Attending, Memorial Sloan Kettering Cancer Center,
Hematopathology Service, Departments of Pathology and Mark A. Crowther, MD, MSc, FRCPC
Laboratory Medicine, New York, New York Professor of Medicine and Pathology and Molecular Medicine,
Hodgkin Lymphoma: Clinical Manifestations, Staging, and Therapy Medicine, McMaster University, Hamilton, Ontario, Canada
Hematologic Manifestations of Renal Disease

